Investors

Cugene is a clinical-stage biotechnology company focused on developing and commercializing next-gen precision immunology and oncology medicines that harness specific immune cells to treat autoimmune disease and cancer. We are seeking strategic partners and investors to accelerate our pipeline advancement.

cugene
411 Waverley Oaks Rd, Ste 142
waltham, MA 02452
USA

Investor inquiries: IR@cugene.com.